Evard v. Monsanto Co.

Plain English (For Everyone)

Imagine you bought a product and later got sick, believing the product caused your illness. This case says that even if the company didn't warn you about potential risks, you still need to prove that the lack of warning directly led to your sickness. Simply getting sick after using a product isn't enough; you have to show the warning would have changed your actions and prevented the illness.

For Legal Practitioners

The court affirmed the dismissal of the plaintiff's failure-to-warn claim, holding that the evidence was insufficient to establish proximate cause. Crucially, the plaintiff failed to demonstrate that a different warning would have altered the consumer's conduct, thereby preventing the injury. This reinforces the heightened burden of proof on plaintiffs in product liability cases to show not just a defect or omission, but a direct causal link between the alleged inadequacy and the resulting harm.

For Law Students

This case tests the elements of a failure-to-warn product liability claim, specifically proximate cause. The court's holding emphasizes that a plaintiff must prove not only that the defendant failed to provide an adequate warning but also that this failure was the direct and foreseeable cause of the injury. This aligns with general tort principles requiring a but-for and proximate cause link between the breach of duty and the damages suffered, highlighting the importance of demonstrating altered conduct.

Newsroom Summary

A court has ruled that a cancer patient failed to prove his illness was directly caused by Monsanto's failure to warn about Roundup risks. The decision means individuals suing over product risks must show a warning would have changed their behavior to prevent harm.

Procedural Posture

Plaintiff, a farmer, sued Monsanto alleging that its Roundup herbicide caused his non-Hodgkin lymphoma. The circuit court dismissed the case, finding that the Illinois Pesticide Act preempted the plaintiff's claims. The plaintiff appealed this dismissal to the Illinois Appellate Court.

Statutory References

Constitutional Issues

Whether the Illinois Pesticide Act preempts common law tort claims related to the use of registered pesticides.

Key Legal Definitions

Rule Statements

The Illinois Pesticide Act does not expressly preempt common law tort claims.

The court must determine whether the Illinois Pesticide Act implicitly preempts common law tort claims.

Scenario: You've been using a household cleaning product for years and recently developed a health condition. You believe the manufacturer should have warned you about this specific risk, but you're unsure if you can sue.

Your Rights: You have the right to sue if a manufacturer fails to warn about a known, unreasonable risk associated with their product. However, you must be able to prove that if the manufacturer had provided a proper warning, you would have acted differently and avoided the injury.

What To Do: Consult with an attorney specializing in product liability. Gather all evidence of your product use, your medical condition, and any information about the manufacturer's warnings. Be prepared to demonstrate how a different warning would have directly impacted your decision-making and prevented your harm.

Is it legal for a company to sell a product without warning about all possible health risks?

It depends. Companies must warn about known, unreasonable risks that consumers wouldn't discover on their own. However, if a consumer develops a health issue, they must prove that the lack of warning directly caused their injury, meaning they would have acted differently if warned.

This principle applies broadly across the United States, but specific requirements for warnings and proof of causation can vary by state law.

For Consumers using herbicides like Roundup

Consumers must now be prepared to demonstrate that a warning about potential health risks would have directly altered their behavior and prevented their injury. Simply developing a condition after using a product is insufficient to establish liability for failure to warn.

For Manufacturers and product designers

This ruling reinforces the need for clear and adequate warnings about known risks. However, it also provides some protection by requiring plaintiffs to prove that the warning's absence was the direct cause of their harm, not just a contributing factor.

Q: What is Evard v. Monsanto Co. about?

Evard v. Monsanto Co. is a case decided by Illinois Appellate Court on November 13, 2025.

Q: What court decided Evard v. Monsanto Co.?

Evard v. Monsanto Co. was decided by the Illinois Appellate Court, which is part of the IL state court system. This is a state appellate court.

Q: When was Evard v. Monsanto Co. decided?

Evard v. Monsanto Co. was decided on November 13, 2025.

Q: What is the citation for Evard v. Monsanto Co.?

The citation for Evard v. Monsanto Co. is 2025 IL App (1st) 241235. Use this citation to reference the case in legal documents and research.

Q: What is the full case name and citation for the Evard v. Monsanto Co. decision?

The full case name is Evard v. Monsanto Co., and it was decided by the Illinois Appellate Court. The specific citation is not provided in the summary, but it is a published opinion from that court.

Q: Who were the main parties involved in the Evard v. Monsanto Co. lawsuit?

The main parties were the plaintiff, Mr. Evard, who sued Monsanto Co., the defendant. Mr. Evard alleged that Monsanto's product, Roundup herbicide, caused him to develop non-Hodgkin's lymphoma.

Q: What was the primary product at issue in Evard v. Monsanto Co.?

The primary product at issue was Monsanto's herbicide, Roundup. The plaintiff, Mr. Evard, claimed that exposure to Roundup caused his non-Hodgkin's lymphoma.

Q: What specific health condition did the plaintiff, Evard, claim was caused by Roundup?

Mr. Evard claimed that his non-Hodgkin's lymphoma was caused by his exposure to Monsanto's Roundup herbicide. This was the central allegation of his lawsuit against the company.

Q: What was the core legal dispute in Evard v. Monsanto Co. regarding Monsanto's product?

The core legal dispute revolved around whether Monsanto adequately warned consumers about the potential risks associated with using its Roundup herbicide. The plaintiff argued the warnings were insufficient.

Q: What was the ultimate outcome of the Evard v. Monsanto Co. case at the appellate level?

The Illinois Appellate Court affirmed the trial court's decision. This means the appellate court agreed with the trial court's ruling that the evidence was insufficient to support the jury's verdict in favor of Mr. Evard.

Q: Is Evard v. Monsanto Co. published?

Evard v. Monsanto Co. is a published, precedential opinion. Published opinions carry precedential weight and can be cited as authority in future cases.

Q: What topics does Evard v. Monsanto Co. cover?

Evard v. Monsanto Co. covers the following legal topics: Daubert standard for admissibility of expert testimony, Causation in toxic tort litigation, Non-Hodgkin lymphoma and glyphosate exposure, Admissibility of scientific evidence, Appellate review of evidentiary rulings.

Q: What was the ruling in Evard v. Monsanto Co.?

The court ruled in favor of the defendant in Evard v. Monsanto Co.. Key holdings: The court held that the plaintiff failed to present sufficient evidence to establish a causal link between Monsanto's failure to warn about Roundup's risks and the plaintiff's non-Hodgkin's lymphoma.; The court found that the jury's verdict in favor of the plaintiff was not supported by the evidence presented at trial, particularly regarding proximate causation.; The court affirmed the trial court's decision to grant Monsanto's motion for judgment notwithstanding the verdict (JNOV), concluding that no reasonable jury could have found for the plaintiff based on the evidence.; The court determined that the plaintiff's expert testimony, while identifying glyphosate as a potential carcinogen, did not adequately bridge the gap to prove that Monsanto's specific failure to warn was the proximate cause of the plaintiff's specific injury.; The court rejected the plaintiff's argument that Monsanto's failure to warn created a question of fact for the jury, finding the evidence on causation too speculative..

Q: Why is Evard v. Monsanto Co. important?

Evard v. Monsanto Co. has an impact score of 65/100, indicating significant legal impact. This decision underscores the critical importance of proving proximate causation in product liability cases, particularly in toxic tort litigation. Future plaintiffs must present robust evidence directly linking a manufacturer's failure to warn to their specific injury, rather than relying solely on general scientific evidence about a product's potential risks.

Q: What precedent does Evard v. Monsanto Co. set?

Evard v. Monsanto Co. established the following key holdings: (1) The court held that the plaintiff failed to present sufficient evidence to establish a causal link between Monsanto's failure to warn about Roundup's risks and the plaintiff's non-Hodgkin's lymphoma. (2) The court found that the jury's verdict in favor of the plaintiff was not supported by the evidence presented at trial, particularly regarding proximate causation. (3) The court affirmed the trial court's decision to grant Monsanto's motion for judgment notwithstanding the verdict (JNOV), concluding that no reasonable jury could have found for the plaintiff based on the evidence. (4) The court determined that the plaintiff's expert testimony, while identifying glyphosate as a potential carcinogen, did not adequately bridge the gap to prove that Monsanto's specific failure to warn was the proximate cause of the plaintiff's specific injury. (5) The court rejected the plaintiff's argument that Monsanto's failure to warn created a question of fact for the jury, finding the evidence on causation too speculative.

Q: What are the key holdings in Evard v. Monsanto Co.?

1. The court held that the plaintiff failed to present sufficient evidence to establish a causal link between Monsanto's failure to warn about Roundup's risks and the plaintiff's non-Hodgkin's lymphoma. 2. The court found that the jury's verdict in favor of the plaintiff was not supported by the evidence presented at trial, particularly regarding proximate causation. 3. The court affirmed the trial court's decision to grant Monsanto's motion for judgment notwithstanding the verdict (JNOV), concluding that no reasonable jury could have found for the plaintiff based on the evidence. 4. The court determined that the plaintiff's expert testimony, while identifying glyphosate as a potential carcinogen, did not adequately bridge the gap to prove that Monsanto's specific failure to warn was the proximate cause of the plaintiff's specific injury. 5. The court rejected the plaintiff's argument that Monsanto's failure to warn created a question of fact for the jury, finding the evidence on causation too speculative.

Q: What cases are related to Evard v. Monsanto Co.?

Precedent cases cited or related to Evard v. Monsanto Co.: Smith v. Illinois Central R.R. Co., 2014 IL App (5th) 121044-CA; Wrobel v. City of Chicago, 2015 IL App (1st) 132311.

Q: What was the appellate court's main reason for affirming the trial court's decision in Evard v. Monsanto Co.?

The appellate court found that the evidence presented was insufficient to establish that Monsanto's failure to warn about Roundup's risks was the proximate cause of Mr. Evard's cancer. The jury's verdict was therefore not supported by the evidence.

Q: What legal standard did the court apply when reviewing the jury's verdict in Evard v. Monsanto Co.?

The court applied a standard of review to determine if the jury's verdict was supported by the evidence. Specifically, it found the evidence insufficient to establish proximate cause, meaning the plaintiff failed to prove Monsanto's actions directly led to his injury.

Q: What does 'proximate cause' mean in the context of the Evard v. Monsanto Co. ruling?

Proximate cause means that the defendant's action (or inaction, like a failure to warn) was a direct and foreseeable cause of the plaintiff's injury. In Evard v. Monsanto Co., the court found the plaintiff did not sufficiently prove that Monsanto's failure to warn directly caused his cancer.

Q: Did the court in Evard v. Monsanto Co. find that Roundup is inherently dangerous?

The opinion summary does not state whether the court found Roundup inherently dangerous. Instead, the focus was on whether Monsanto provided adequate warnings and whether the failure to warn was the proximate cause of Mr. Evard's specific cancer.

Q: What was the burden of proof on Mr. Evard in his lawsuit against Monsanto?

Mr. Evard had the burden of proving that Monsanto's failure to warn about Roundup was a proximate cause of his non-Hodgkin's lymphoma. The appellate court determined he did not meet this burden with the evidence presented.

Q: How did the appellate court analyze the sufficiency of the evidence regarding causation in Evard v. Monsanto Co.?

The court analyzed whether the evidence presented at trial was legally sufficient to link Monsanto's failure to warn directly to Mr. Evard's cancer. It concluded that the evidence did not establish this crucial causal connection.

Q: Does the Evard v. Monsanto Co. decision mean Roundup is safe?

The decision in Evard v. Monsanto Co. does not definitively declare Roundup safe. It specifically ruled that the plaintiff failed to present sufficient evidence to prove that Monsanto's failure to warn was the proximate cause of his particular cancer.

Q: What is the significance of the appellate court affirming the trial court's decision in this case?

Affirming the trial court's decision means the appellate court agreed with the lower court's judgment. In this instance, it upheld the finding that the jury's verdict for Mr. Evard was not supported by adequate evidence, particularly on the issue of causation.

Q: What legal doctrines regarding product liability were central to the Evard v. Monsanto Co. case?

The central doctrines were failure-to-warn and proximate cause. Mr. Evard alleged Monsanto failed to adequately warn about Roundup's risks, and the court's decision focused on whether this failure was proven to be the direct cause of his illness.

Q: How does Evard v. Monsanto Co. affect me?

This decision underscores the critical importance of proving proximate causation in product liability cases, particularly in toxic tort litigation. Future plaintiffs must present robust evidence directly linking a manufacturer's failure to warn to their specific injury, rather than relying solely on general scientific evidence about a product's potential risks. As a decision from a state appellate court, its reach is limited to the state jurisdiction. This case is moderate in legal complexity to understand.

Q: What are the practical implications of the Evard v. Monsanto Co. ruling for consumers?

For consumers, this ruling suggests that simply alleging a product caused harm is not enough; they must also provide sufficient evidence to prove a direct causal link, especially concerning failure-to-warn claims. It highlights the importance of meeting the burden of proof on proximate cause.

Q: How might the Evard v. Monsanto Co. decision affect future lawsuits against herbicide manufacturers?

Future lawsuits against herbicide manufacturers, particularly those based on failure-to-warn claims, may face higher scrutiny regarding the evidence of causation. Plaintiffs will need to present stronger proof that the alleged inadequate warning was the direct cause of their specific injury.

Q: What does this case imply for companies like Monsanto regarding product warnings?

Companies like Monsanto must ensure their product warnings are not only present but also demonstrably adequate. However, this case also shows that even with potentially inadequate warnings, a plaintiff must still prove causation to win their case.

Q: Who is most affected by the outcome of Evard v. Monsanto Co.?

Individuals who have developed cancer and believe it was caused by products like Roundup are most directly affected. They face a significant challenge in proving the necessary legal elements, like proximate cause, to succeed in their claims.

Q: Does this ruling impact the sale or availability of Roundup herbicide?

The ruling in Evard v. Monsanto Co. itself does not directly impact the sale or availability of Roundup. It is a decision on a specific plaintiff's case and does not constitute a ban or restriction on the product.

Q: How does the Evard v. Monsanto Co. decision fit into the broader legal landscape of product liability cases?

This case fits into product liability law by reinforcing the plaintiff's burden to prove causation. It illustrates that courts will scrutinize the evidence linking a defendant's alleged defect or failure to warn with the plaintiff's specific harm.

Q: Are there other landmark cases concerning herbicide liability that Evard v. Monsanto Co. might be compared to?

While not explicitly mentioned, Evard v. Monsanto Co. can be compared to other product liability cases involving alleged health risks from chemicals. These often hinge on scientific evidence of causation and the adequacy of warnings, similar to cases involving asbestos or tobacco.

Q: What was the docket number in Evard v. Monsanto Co.?

The docket number for Evard v. Monsanto Co. is 1-24-1235. This identifier is used to track the case through the court system.

Q: Can Evard v. Monsanto Co. be appealed?

Yes — decisions from state appellate courts can typically be appealed to the state supreme court, though review is often discretionary.

Q: How did the case of Evard v. Monsanto Co. reach the Illinois Appellate Court?

The case reached the appellate court through an appeal filed by Mr. Evard after the trial court ruled against him, likely following a jury verdict or a directed verdict. The appellate court reviewed the trial court's proceedings for errors of law or fact.

Q: What procedural issue was key to the appellate court's decision in Evard v. Monsanto Co.?

The key procedural issue was the sufficiency of the evidence presented at trial to support the jury's verdict. The appellate court reviewed whether the evidence met the legal threshold for proving causation, ultimately finding it did not.

Q: Did the appellate court in Evard v. Monsanto Co. re-try the facts of the case?

No, the appellate court does not re-try the facts. Instead, it reviews the record from the trial court to determine if the judge made legal errors or if the jury's verdict was unsupported by the evidence presented during the trial.